AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionRoundview Capital LLC
Latest Disclosed Ownership29,849 shares
Latest Disclosed Value $ 6,491,860
Roundview Capital LLC reports 1.23% increase in ownership of 4AB / AbbVie Inc.

On May 8, 2026 - Roundview Capital LLC filed a 13F-HR form disclosing ownership of 29,849 shares of AbbVie Inc. (BG:4AB) valued at $6,491,860 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 29,487 shares of AbbVie Inc.. This represents a change in shares of 1.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ABBVIE COM 00287Y109 29,849 362 1.23 6,492 -3.65 0.4044
2026-02-09 2025-12-31 13F ABBVIE COM 00287Y109 29,487 86 0.29 6,737 -1.03 0.4144
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 29,401 151 0.52 6,808 25.38 0.4304
2025-07-23 2025-06-30 13F ABBVIE COM 00287Y109 29,250 329 1.14 5,429 -10.40 0.3629
2025-05-06 2025-03-31 13F ABBVIE COM 00287Y109 28,921 201 0.70 6,060 18.73 0.4372
2025-02-12 2024-12-31 13F ABBVIE COM 00287Y109 28,720 765 2.74 5,103 -7.55 0.3563
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 27,955 87 0.31 5,521 15.51 0.3999
2024-08-09 2024-06-30 13F ABBVIE COM 00287Y109 27,868 428 1.56 4,780 -4.34 0.3765
2024-05-06 2024-03-31 13F ABBVIE COM 00287Y109 27,440 722 2.70 4,997 20.68 0.4085
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 26,718 -5,554 -17.21 4,140 -13.93 0.3817
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 32,272 -56 -0.17 4,811 10.45 0.4837
2023-08-09 2023-06-30 13F ABBVIE COM 00287Y109 32,328 99 0.31 4,356 -15.21 0.4252
2023-05-09 2023-03-31 13F ABBVIE COM 00287Y109 32,229 331 1.04 5,136 -0.37 0.5373
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 31,898 442 1.41 5,155 22.10 0.5882
2022-11-10 2022-09-30 13F ABBVIE COM 00287Y109 31,456 501 1.62 4,222 -10.95 0.5330
2022-08-11 2022-06-30 13F ABBVIE COM 00287Y109 30,955 218 0.71 4,741 -4.86 0.5676
2022-05-17 2022-03-31 13F/A-1 ABBVIE COM 00287Y109 30,737 -4,657 -13.16 4,983 3.99 0.5120
2022-05-11 2022-03-31 13F ABBVIE COM 00287Y109 30,737 -4,657 4,983 0.4945
2022-02-10 2021-12-31 13F ABBVIE COM 00287Y109 35,394 -271 -0.76 4,792 24.56 0.4779
2021-11-10 2021-09-30 13F ABBVIE COM 00287Y109 35,665 1,584 4.65 3,847 0.21 0.4240
2021-08-10 2021-06-30 13F ABBVIE COM 00287Y109 34,081 3,644 11.97 3,839 16.55 0.4283
2021-05-14 2021-03-31 13F ABBVIE COM 00287Y109 30,437 -5,808 -16.02 3,294 -15.19 0.4145
2021-02-08 2020-12-31 13F ABBVIE COM 00287Y109 36,245 -6,257 -14.72 3,884 4.32 0.5313
2020-11-05 2020-09-30 13F ABBVIE COM 00287Y109 42,502 -10,800 -20.26 3,723 -28.86 0.5841
2020-08-13 2020-06-30 13F ABBVIE COM 00287Y109 53,302 7,831 17.22 5,233 51.07 0.8888
2020-05-11 2020-03-31 13F ABBVIE COM 00287Y109 45,471 16,038 54.49 3,464 32.92 0.7323
2020-02-10 2019-12-31 13F ABBVIE COM 00287Y109 29,433 15,548 111.98 2,606 147.95 0.4953
2019-11-12 2019-09-30 13F ABBVIE COM 00287Y109 13,885 3,748 36.97 1,051 42.41 0.2268
2019-08-12 2019-06-30 13F ABBVIE COM 00287Y109 10,137 -1,054 -9.42 738 -18.18 0.1662
2019-05-09 2019-03-31 13F ABBVIE COM 00287Y109 11,191 338 3.11 902 -9.89 0.2143
2019-02-13 2018-12-31 13F ABBVIE COM 00287Y109 10,853 470 4.53 1,001 1.93 0.2807
2018-11-07 2018-09-30 13F AbbVie COM 00287Y109 10,383 1,577 17.91 982 20.34 0.2423
2018-08-10 2018-06-30 13F AbbVie COM 00287Y109 8,806 -45 -0.51 816 -2.63 0.2139
2018-05-14 2018-03-31 13F AbbVie COM 00287Y109 8,851 -5,636 -38.90 838 -40.19 0.2359
2018-02-07 2017-12-31 13F AbbVie COM 00287Y109 14,487 -224 -1.52 1,401 7.19 0.3619
2017-11-13 2017-09-30 13F/A-1 AbbVie COM 00287Y109 14,711 6,400 77.01 1,307 116.75 0.3739
2017-11-13 2017-09-30 13F AbbVie COM 00287Y109 8,311 0 603 175,905.8568
2017-08-11 2017-06-30 13F AbbVie COM 00287Y109 8,311 -22,265 -72.82 603 -69.73 0.1759
2017-05-11 2017-03-31 13F AbbVie COM 00287Y109 30,576 -4,000 -11.57 1,992 -7.99 0.6184
2017-02-14 2016-12-31 13F AbbVie COM 00287Y109 34,576 -3,200 -8.47 2,165 -9.15 0.6949
2016-11-14 2016-09-30 13F AbbVie COM 00287Y109 37,776 -400 -1.05 2,383 0.85 0.8421
2016-08-12 2016-06-30 13F AbbVie COM 00287Y109 38,176 -150 -0.39 2,363 7.95 0.8697
2016-05-12 2016-03-31 13F AbbVie COM 00287Y109 38,326 -2,337 -5.75 2,189 -9.13 0.8160
2016-02-11 2015-12-31 13F AbbVie COM 00287Y109 40,663 13,000 46.99 2,409 60.07 0.9544
2015-11-12 2015-09-30 13F AbbVie COM 00287Y109 27,663 21,575 354.39 1,505 267.97 0.6454
2015-08-14 2015-06-30 13F AbbVie COM 00287Y109 6,088 1,471 31.86 409 51.48 0.1540
2015-05-15 2015-03-31 13F AbbVie COM 00287Y109 4,617 0 0.00 270 -10.60 0.1068
2015-02-13 2014-12-31 13F AbbVie COM 00287Y109 4,617 0 0.00 302 13.11 0.1240
2014-11-14 2014-09-30 13F AbbVie COM 00287Y109 4,617 0 0.00 267 2.30 0.1201
2014-08-08 2014-06-30 13F AbbVie COM 00287Y109 4,617 0 0.00 261 10.13 0.1055
2014-04-30 2014-03-31 13F AbbVie COM 00287Y109 4,617 0 0.00 237 -2.87 0.1151
2014-02-12 2013-12-31 13F AbbVie COM 00287Y109 4,617 -100 -2.12 244 15.64 0.1118
2013-11-12 2013-09-30 13F AbbVie COM 00287Y109 4,717 4,717 211 0.1096
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.